Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma

Acta Haematol (2019) 141 (3): 187–188.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Gemcitabine, Dexamethasone, Cisplatin with Rituximab in Treatment Transplant- Ineligible Relapsed Non-Hodgkin B-cell Lymphoma Patients

Tuan Tung Nguyen
Van Hung Nguyen
Minh Phuong Vu

Clinical Cancer Investigation Journal (2022) 11 (3): 15.